Real‐world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
Publisher: John Wiley & Sons Inc
E-ISSN: 1440-1746|33|3|710-717
ISSN: 0815-9319
Source: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.3, 2018-03, pp. : 710-717
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract